What You Should Know:
– Coalesce Capital (“Coalesce”), a private equity firm focused on investing in human capital-driven and technology-enabled services companies announced it has acquired a majority stake in DAS Health Ventures (“DAS Health”), a provider of healthcare IT and business solutions.
– Sheridan Capital Partners (“Sheridan”), which first invested in DAS Health in 2021, will retain a minority ownership position and continue to support the company’s ongoing growth initiatives.
DAS Health Background
DAS Health provides a comprehensive suite of IT, cybersecurity, revenue cycle management, and business solutions to thousands of healthcare organizations across North America, aiming to streamline workflows, increase productivity, and improve patient care. This new partnership with Coalesce is set to fuel DAS Health’s expansion by investing in technology, talent, and strategic acquisitions.
The investment from Coalesce Capital marks a significant milestone for DAS Health as it seeks to broaden its reach and enhance its service offerings.
“We are thrilled to welcome Coalesce Capital as we embark on this next chapter for DAS Health,” said Michelle Jaeger, President & CEO of DAS Health. “Their investment underscores our commitment to delivering innovative solutions that help healthcare organizations operate more efficiently and improve patient care. With Sheridan’s continued support, we are well-positioned to broaden our reach and help even more providers achieve operational excellence and better outcomes.”
